0NX.F VOXEL SA ZY 1

Healthcare Biotechnology Frankfurt Exchange
34.10 EUR
Close of Nov 11, 2026
21.28 36.90
Market cap
EUR 358M
P/E
12.5x
P/B
3.69x
ROE
29.3%
Dividend yield
1.68%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0NX.F undervalued?

Graham number
Price34.10
Graham value23.79
Premium43.3%

0NX.F trades 43.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VOXEL SA ZY 1 fundamental analysis

No fundamental analysis for VOXEL SA ZY 1 yet.

VOXEL SA ZY 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VOXEL SA ZY 1

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.

Full company profile